Galya Blachman

Galya Blachman

General Counsel at 501 ACQU
49 year
Consumer Services
Health Technology
Finance

Profile

Galya D.
Blachman
is currently Chief Legal Officer & Head-Business Development at Enliven Therapeutics, Inc. since 2023.
Legal Advisor at 5AM Venture Management LLC since 2022.
Secretary & General Counsel at 5:01 Acquisition Corp.
since 2020.
General Counsel at Biotech Connection-Bay Area, Inc. since 2018.
Formerly Legal Director at Stemcentrx, Inc. from 2012 to 2017.
Also worked as Head-Legal, Research & Development at AbbVie Stemcentrx LLC.
Education includes a doctorate from the University of Cambridge in 2004, a graduate degree from the University of Oxford in 2009, graduate and undergraduate degrees from the University of Cape Town in 2001 and 2000 respectively, and a graduate degree from BPP Law School in 2006.

Galya Blachman active positions

CompaniesPositionStart
501 ACQU General Counsel 01/09/2020
ENLIVEN THERAPEUTICS, INC. General Counsel 01/07/2023
General Counsel 01/06/2018
General Counsel 01/09/2018

Former positions of Galya Blachman

CompaniesPositionEnd
General Counsel 01/01/2017
AbbVie Stemcentrx LLC
Corporate Officer/Principal -
See the detail of Galya Blachman's experience

Training of Galya Blachman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

89

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Consumer Services

Consumer Services

Finance

Consumer Services

AbbVie Stemcentrx LLC

Finance

Health Technology

  1. Stock Market
  2. Insiders
  3. Galya Blachman